Key result
Angiotensin II type 1 receptor blockers, such as candesartan, provide effective 24-hour blood pressure control and are well tolerated in combination with hydrochlorothiazide for hypertension.
Why the study?
Prognosis in hypertensive patients can be improved by reducing blood pressure and suppressing adverse neurohormonal influences, with initial data suggesting AT1 receptor blockers reduce cardiac and renal damage.
Do angiotensin II type 1 receptor blockers improve prognosis and reduce cardiac and renal damage in hypertensive patients?
Do angiotensin II type 1 receptor blockers improve prognosis and reduce cardiac and renal damage in hypertensive patients?
Angiotensin II type 1 receptor blockers, such as candesartan, provide effective blood pressure control and may reduce cardiac and renal damage in hypertensive patients.
Answers are grounded in this paper and cite their sources.
Neurohormonal suppression may enhance hypertension prognosis beyond BP control; leaves open AT1 blocker outcome benefits in level 4 data.
Prognosis can be improved in hypertensive patients not only by reducing blood pressure, but probably also by effective suppression of adverse neurohormonal influences. Inhibition of the renin-angiotensin system by angiotensin-converting enzyme inhibitors effectively reduces left ventricular hypertrophy and decreases morbidity and mortality due to heart failure, as well as slowing the progression of renal disease. Initial data from studies of angiotensin II type 1 (AT1) receptor blockers indicate that these agents should also be effective in reducing cardiac and renal damage. In this class, candesartan, by virtue of its tight and long-lasting binding to the AT1-receptor, provides pronounced 24-h blood pressure control with effective blockade of all the major negative cardiovascular effects of angiotensin II. Candesartan cilexetil has also been shown to be effective and well tolerated in combination with hydrochlorothiazide in those hypertensive patients who require more than one agent to reach their target blood pressure.
No takes yet. Share an insight, caveat, or question.
Luís M. Ruilope (2000) conducted a review in Hypertension. Angiotensin II Type 1 Receptor Blockers (Candesartan) was evaluated. Angiotensin II type 1 receptor blockers, such as candesartan, provide effective 24-hour blood pressure control and are well tolerated in combination with hydrochlorothiazide for hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: